Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 0.44.

  • Harvard Bioscience's Debt Ratio rose 5097.76% to 0.44 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44, marking a year-over-year increase of 5097.76%. This contributed to the annual value of 0.29 for FY2024, which is 963.21% up from last year.
  • According to the latest figures from Q3 2025, Harvard Bioscience's Debt Ratio is 0.44, which was up 5097.76% from 0.44 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Debt Ratio registered a high of 0.45 during Q1 2025, and its lowest value of 0.27 during Q4 2023.
  • Moreover, its 5-year median value for Debt Ratio was 0.29 (2021), whereas its average is 0.32.
  • In the last 5 years, Harvard Bioscience's Debt Ratio crashed by 1736.98% in 2023 and then skyrocketed by 6849.7% in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Debt Ratio stood at 0.3 in 2021, then grew by 8.2% to 0.32 in 2022, then fell by 17.37% to 0.27 in 2023, then grew by 9.63% to 0.29 in 2024, then skyrocketed by 49.25% to 0.44 in 2025.
  • Its last three reported values are 0.44 in Q3 2025, 0.44 for Q2 2025, and 0.45 during Q1 2025.